- Home
- RFAI vs CATX Comparison
RFAI vs CATX Comparison
Compare RFAI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFAI
- CATX
- Stock Information
- Founded
- RFAI 2024
- CATX 1983
- Country
- RFAI Singapore
- CATX United States
- Employees
- RFAI N/A
- CATX N/A
- Industry
- RFAI
- CATX Medical/Dental Instruments
- Sector
- RFAI
- CATX Health Care
- Exchange
- RFAI NYSE
- CATX Nasdaq
- Market Cap
- RFAI 156.9M
- CATX 182.9M
- IPO Year
- RFAI 2024
- CATX N/A
- Fundamental
- Price
- RFAI $10.48
- CATX $2.34
- Analyst Decision
- RFAI
- CATX Strong Buy
- Analyst Count
- RFAI 0
- CATX 10
- Target Price
- RFAI N/A
- CATX $13.89
- AVG Volume (30 Days)
- RFAI 10.3K
- CATX 619.9K
- Earning Date
- RFAI 01-01-0001
- CATX 05-12-2025
- Dividend Yield
- RFAI N/A
- CATX N/A
- EPS Growth
- RFAI N/A
- CATX N/A
- EPS
- RFAI N/A
- CATX N/A
- Revenue
- RFAI N/A
- CATX $1,454,000.00
- Revenue This Year
- RFAI N/A
- CATX N/A
- Revenue Next Year
- RFAI N/A
- CATX N/A
- P/E Ratio
- RFAI $45.55
- CATX N/A
- Revenue Growth
- RFAI N/A
- CATX 1.40
- 52 Week Low
- RFAI $10.00
- CATX $1.60
- 52 Week High
- RFAI $10.50
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- RFAI N/A
- CATX 51.17
- Support Level
- RFAI N/A
- CATX $2.18
- Resistance Level
- RFAI N/A
- CATX $2.65
- Average True Range (ATR)
- RFAI 0.00
- CATX 0.16
- MACD
- RFAI 0.00
- CATX 0.02
- Stochastic Oscillator
- RFAI 0.00
- CATX 56.25
About RFAI RF ACQUISITION CORP II
RF Acquisition Corp II is a blank check company.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.